ARCHIVES

Committee Unblinds Phase III Zytiga Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Only Three Of 28 CCRU, CCSP Proposals Approved, But DRCCA Will Try Again, Board OKs New RFAs

May 13, 1983

FDA Approves New Indication For Anticoagulant Frangmin

May 25, 2007

NCI Intends To Extend OSCC Two More Years

October 3, 1986

SWOG Phase III Trial To Test Treatment For Inoperable, Locally Advanced NSCLC

September 28, 2001

Varmus Discusses Grant Policy, Changes in Congress and Ebola

December 12, 2014

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

September 27, 2002